8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.001952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Paula Reginatto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Ps-Graduao em Cincias Farmacuticas, Faculdade de Farmcia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Antifungal Agents, Fusarium, Eye Infections, Fungal, Microbial Sensitivity Tests. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Introduction
Ocular fungal infections are pathologies of slow progression, occurring mainly in the cornea, but can also affect the entire structure of the eyeball. The main aetiological agents are species of the genera Candida and Fusarium . Both diagnosis and treatment require speed and effectiveness. However, the currently available therapy basically consists of the use of azoles and polyenes, known for their low penetration into the ocular tissue and the associated toxicity. Hypothesis. Thus, new strategies to combat these infections are needed, such as the development of new antifungals or the use of associations.
Aim
Thus, the compound PH151, derived from a promising class of 8-hydroxyquinolines, and natamycin, amphotericin B (AMB) and voriconazole (VRC), the main antifungals used in ocular antifungal therapy, were considered against Candida spp. and Fusarium spp. Methodology. The MICs of compound PH151 ranged from 1.0 to 16.0 µg ml −1 , according to CLSI protocols.
Results
The association of PH151 with AMB and VRC showed a synergistic effect for more than 50% of the strains tested.
Conclusion
Both the compound alone and its association (VRC-AMB-PH151) demonstrated promising potential as an antifungal agent in ocular infections, since the evaluated ocular toxicity profile was positive and the compounds presented low toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Ps-Graduao em Cincias Farmacuticas, Faculdade de Farmcia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
- Faculty of Pharmacy of the Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
- Instituto Federal Catarinense, Concrdia, Brazil.
- Departamento de Anlises, Faculdade de Farmcia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Departamento de Produo de Matria-Prima, Faculdade de Farmcia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Reginatto, P., Joaquim, A. R., Teixeira, M. L., Andrade, S. F., & Fuentefria, A. M. (2025). 8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001952
Vancouver
Reginatto P, Joaquim AR, Teixeira ML, Andrade SF, Fuentefria AM. 8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.001952
BibTeX
@article{Reginatto2025,
author = {Reginatto, Paula and Joaquim, Angélica Rocha and Teixeira, Mário Littieri and Andrade, Saulo Fernandes de and Fuentefria, Alexandre Meneghello},
title = {8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.001952}
}
EUVIMED